The one that can’t be beat is the one that can’t be replaced. After more than 25 years, Bursine-2, an intermediate infectious bursal disease (IBD) vaccine, continues to reliably perform in the field around the world. The superior performance of Bursine-2 results from its cross-protective nature, safety, speed of replication and ability to protect the immune system.